Ani Pharmaceuticals Inc (ANIP)

R&D Expenses

$14.75M

Quarterly · Period ending: · USD

ANIP logo

ANIP R&D Expenses

Latest reported$14.75M
ANIP Quarterly R&D Expenses ($145.51K → $14.75M)
High-resolution chart · PNG

ANIP r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ani Pharmaceuticals Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
387,236
232,989
293,070
239,548
1,164,039
191,175
145,509
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.